Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2020
Source ID
10.1016/j.jtocrr.2020.100071

Entities

People

  • Andrew J. Piper-vallillo
  • Brian T. Halbert
  • Daniel B Costa
  • Deepa Rangachari
  • Susumu S Kobayashi

Organizations

  • National Cancer Institute
  • United States Department of Defense